The thalassaemias

British Medical Journal

Volumn 314, Issue 7095, 1997, Pages 1675-1678

  Weatherall, D J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; CHELATING AGENT; HEMOGLOBIN;

ANEMIA; BLOOD TRANSFUSION; CHORION VILLUS SAMPLING; DNA DETERMINATION; FETUS DEATH; GENETIC COUNSELING; HEMOGLOBIN SYNTHESIS; HUMAN; IRON CHELATION; IRON DEFICIENCY ANEMIA; MONOGENIC DISORDER; PRIORITY JOURNAL; PROGNOSIS; RACE; SHORT SURVEY; THALASSEMIA;

ALPHA-THALASSEMIA; BETA-THALASSEMIA; FEMALE; HUMANS; MALE; THALASSEMIA;

EID: 0030920808     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Wealherall DJ, CleggJB. Thalassemia-a global public health problem. Mature Med 1996:3:47-9.
2. Weatherall DJ, Clegg JB. The thalassaemia syndromes. 3rd ed. Oxford: Blackw ell Scientific, 1981.
3. Weatherall DJ. Thalassemia. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The molecular basis of blood diseases. Vol 2. Philadelphia: Saunders, 1994:157-206.
4. Higgs DR, Weatherall DJ, ed. Clinifal haematology. Vol 6. Tlie haemeglobinopathies. London: Baillière Tindall, 1993.
5. Weatherall DJ, Letsky EA. Screening and prenatal diagnosis of haematological disorders. In: Wald N, ed. Antenatal and neonatal screening. 2nd ed. Oxford: Oxford University Press (in press).
6. Weatherall DJ. The role of recent studies of the molecular pathology of the thalassaemias in their control and management. In: McArthurJR, Lee SH, Wong JEL, Ong YW, eds. Haematology 1996. Education programme of the 26th congress of the. International Society of Haematology. Singapore: ICH, 1996:11-4.
7. Wasi P. Thalassaemia: clinical aspects and screening. In: McArthur JR, Lee SH, Wong JEL, Ong YW, eds. Haematology 1996. Education Programme of the 26th congress of the lilternational Society of Haematology. Singapore: ICH, 1996:226-33.
8. Huisman THJ. Molecular genetics of a-thalassemia. In: McArthur RJ, Lee SH, WongJEL, Ong YW, eds. Haematology 1996. Education Programme of the 26th congress of the International Society of Haematology. Singapore: ICH, 1996:233-6.
9. Thein SL. Molecular genetics of -thalassaemia. In: McArthur JR. Lee SH, WongJEL, Ong YW, eds. Haematology 1996. Education Programme of the 26th congress of the International Society of Haematology. Singapore: ICH, 1996:236-40.
10. Hofibrand AV. Oral iron chelation therapy. In: McArthurJR, Lee SH, Wong JEL, Ong YW, eds. Haematology 1996. Education Programme of the 26th congress of the International Society of Haematology. Singapore: ICH, 1996:241-4.
11. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TEA, Newbold CI, et al. High incidence of malaria in athalassaemic children. Nature (in press).
12. Thein SL. β-Thalassaemia. Clin Hatmatol 1993;6:151-75.
13. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
14. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β thalassemia. N Engl J Med 1994:331:574-8.
15. Weatherall DJ. The molecular basis for phenotypic variability of the common thalassaemias. Mol Med Today 1996;1:15-20.
16. Higgs DR. α-Thalassaemia. din Haematol 1993;6:117-50.
17. World Health Organisation. Working Group on the Community Control of Hereditary Anaemias. Bull WHO 1983;61:63-80.
18. Cao A, Rosatelli MC. Screening and prenatal diagnosis of the haemoglobinopathies. Clin Haematol 1993:6:263-86.
19. Modell BMP, Layton M, Petrou M, Layton M, Varnavides L, Ward RHT, Rodeck C, et al. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. BMJ (in press).
20. Brittenham GM, Cohen AR, McLaren C, Martin MB, Griffith MM, Niewhuis AW, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia. Am J Hematol 1993;42:81-5.
21. Olivieri NE Iron chelating therapy and the treatment of thalassemia. Blood 1997;89:739-61.
22. Porter JB, Huehns ER. The toxic effects of desferrioxamine. Clin Haematol 1989;2:459-74.
23. Olivieri NF, Harris J, Koren G, Harris J, Khattak S, Freedman MH, et al. Growth failure and bony changes induced by deferoxamine. Am J Ped Hem Oncol 1992:14:48-56.
24. Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blandis LM, Cameron RG, et ai Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med 1995:332:918-22.
25. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993:329:840-4.
26. Olivieri NF. Clinical experience with reactivation of fetal hemoglobin in the beta hemoglobinopathies. Sem Hematol 1995;33:24-42.